Skedgel, C. ., Wranik, D. ., & Hu, M. . (2018). The Relative Importance of Clinical, Economic, Patient Values and Feasibility Criteria in Cancer Drug Reimbursement in Canada: A Revealed Preferences Analysis of Recommendations of the Pan-Canadian Oncology Drug Review 2011-2017. PharmacoEconomics. https://doi.org/10.1007/s40273-018-0610-0 (Original work published 2018)